11 1 3 ite 1

alt a e it 41 4
stome e vi e: support@nomitesting.com

Xavier M Gil
610 S 800 W #30
Payson, UT 84651-2625

Test Report
Patient Date of Birth Report Date/Time Collection Date/Time Medical Record Number
Xavier M Gil 11/21/2010 1/16/2022 10:06AM 1/16/2022 9:51AM 26395-00343
Test Employee ID Result Type of
Test
SARS-CoV-2 N/A Negative COVID-Ag

Name and Address of Lab Where Test Was Performed

Provo Town Centre Mall (Appointment Only) Open M-Su 7am-7pm: 1200 Towne Centre Blvd., Provo,
lfUT
your is NEGATIVE for SARS-CoV-2 (coronavirus 2), the virus that causes COVID-19 this may mean you were
resultUSA
84601,
not infected at the time your test was performed or there was not enough virus present to be detected.

If your result is POSITIVE for SARS-CoV-2 (Coronavirus 2), the virus that causes COVID-19, you were infected with
COVID-19 at the time of testing.

If you receive an INVALID or REJECTED test result, it means that the sample you provided was non-optimal and could
not be tested or could not produce appropriate data to determine whether or not you are infected with the virus. If you
receive an invalid/rejected test result, please re-collect and re-submit a new sample.

CDC guidelines for COVID-19 are updated regularly. For the most up-to-date information on testing, quarantining, and
isolation, please visit the Centers for Disease Control and Prevention websites:
https://www.cdc.gov/coronavirus/2019-ncov/your-health/quarantine-isolation.html
https://www.cdc.gov/coronavirus/2019-ncov/testing/diagnostic-testing.html

Method: The GenBody COVID-19 Ag test is an immunochromatographic rapid diagnostic test (RDT) intended for the
qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) or anterior nasal
(AN) swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within the first six
days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19
when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.

Limitations: There are different kinds of tests for COVID-19. Molecular tests (also known as PCR tests) detect genetic
material from the virus. Antigen tests detect proteins from the virus. Antigen tests are specific for the virus but are not as
sensitive as molecular tests. This means that a positive result is highly accurate, but a negative result does not rule out
infection.

Disclaimer: The GenBody COVID-19 Ag test has not been FDA cleared or approved. It has been authorized by the FDA
under an emergency use authorization for use by authorized entities. The test has been authorized only for the detection
of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the
declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection
and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is
terminated or revoked sooner.

Fact Sheets
https://www.fda.gov/media/150786/download
https://www.fda.gov/media/150787/download